New Data Supporting the Potential Use of Oxbryta® (voxelotor) – GlobeNewswire
CONTEXT: New data being presented at the European Hematology Association (EHA) 2021 Virtual Congress on the treatment of sickle cell disease with Oxbryta (voxelotor). Two real-world evidence studies support the Continue Reading